Preclinical hematological profile studies of an ayurvedic medicine Krishna Chaturmukha after chronic administration to male Sprague-Dawley rats

M. Al Azad; M. Ohidullah; M. Nuruzzaman Neon; M. Mamun Sikder; M. S. K. Choudhuri

doi:10.18203/2319-2003.ijbcp20250476

Authors

M. Al Azad Department of Pharmacy, Jahangirnagar University, Savar, Dhaka-1342, Bangladesh
M. Ohidullah Department of Pharmacy, Jahangirnagar University, Savar, Dhaka-1342, Bangladesh
M. Nuruzzaman Neon Department of Pharmacy, Jahangirnagar University, Savar, Dhaka-1342, Bangladesh
M. Mamun Sikder Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, 345 Weill Hall, Ithaca, NY, 14853, USA
M. S. K. Choudhuri Department of Pharmacy, Jahangirnagar University, Savar, Dhaka-1342, Bangladesh

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20250476

Keywords:

Ayurvedic formulation, Krishna Chaturmukha, Hematological, Neurological disorders

Abstract

Background: Krishna Chaturmukha (KMC) is an ayurvedic formulation predominantly used as a traditional medicine in the rural population to get relief from various neurological disorders.

Methods: The acute pharmacological test of KMC recorded no death or any signs of effectivity even at the highest dose of 4000 mg/kg body weight. The effect of chronic administration of KMC on hematological parameters was determined by administrating chronically to the male Sprague-Dawley rats at a dose of 100 mg per kg body weight for 40 days.

Results: There was a (10.12 %) decrease in the number of white blood cell count of the male rats, which, although not statistically significant yet it was prominent (p=0.248). Similarly, a negligible (0.12 %) decrease in the red blood cell count was observed, which was not statistically significant at all (p=0.965). Conversely, the platelets count showed a (4.99 %) increase in the experimental animals, while this increase was not significant, yet it was prominent (p=0.296). Furthermore, a (1.89 %) decline was observed in the platelet volume distribution width of the experiment rats, which, although not significant, yet it was noticeable (p=0.076).

Conclusions: From this study, it is evident that there is no significant change in the hematological parameters in the body of the treated rats, therefore it is safe to use in usual dose. Further research and analysis with biochemical parameters should be done to reconfirm the safety of this ayurvedic medicine.

Metrics

Metrics Loading ...

References

Shere-Wolfe KD, George N, Al Kibria GM, Silk R, Alexander CS. A multimodal ayurveda and mind–body therapeutic intervention for chronic symptoms attributed to a postinfectious syndrome: a pilot study. J Integr Comp Med. 2024;30(5):450-8. DOI: https://doi.org/10.1089/jicm.2023.0234

Sunitha W. A Study on Users Perception Towards Ayurvedic Medicine with Special Reference to Kanniyakumari District. Shanlax Int J Eco. 2020;8(2):59-64. DOI: https://doi.org/10.34293/economics.v8i2.1476

Ernst E. Pharmacoepidemiol Drug Saf. 2002;11(6):455-6. DOI: https://doi.org/10.1002/pds.756

WHO. WHO Launches the First Global Strategy on Traditional and Alternative Medicine, Press Release, WHO /38: 2002.

Sikder MM, Chakraborty P, Mahbub MR, Zulfiquar TN, Neon MN, Saha N, et al. Preclinical hematological profile studies of an ayurvedic medicine “Siddha Makardhwaja” after chronic administration to male Sprague-dawley rats. Int J Basic Clin Pharmacol. 2018;7:93–7.

Amin MT, Fatema K, Rahman MA, Haque T, Choudhuri MS. Investigation of hemotoxicologic potential of an ayurvedic preparation Kutajarista used in Sprue syndrome after chronic administration to male Sprague-Dawley rats. African J Pharm and Pharmacol. 2020;14(8):308-15.

Hossain S, Sultana N, Sumi SJ, Chowdhuri MS. Effect of Panchatikta Ghrita Guggulu (PTK-G) on Hematological and Biochemical parameters after long term use in Eczematized patients of Bangladesh. Int J Health & Complemen Med. 2022;1(1):56.

Ayurmed Info, Chaturmukha Rasa – Benefits, Dosage, Ingredients, Side effects; Available at https://www.ayurmedinfo.com. Accessed on 21 August 2024.

Pathak M. Indian Journal of Pharmaceutical Education and Research: A Scientometric Analysis. Indian J Pharma Edu Res. 2020;54(2):56. DOI: https://doi.org/10.5530/ijper.54.2.30

Guideline OE. for the testing of chemicals, Guidance document on acute oral toxicity. Environmental health and safety monograph series on testing and assessment. 2008;3:1-27.

Stevens KR. Practical considerations in the conduct of chronic toxicity studies. Principles and methods of toxicology. 1982.

Ringler H, Dabich L. Hematology and clinical biochemistry. In: The Laboratory Rat Biology and Disease. American College of Laboratory Animal Medicine Series Academic Press. 1979. DOI: https://doi.org/10.1016/B978-0-12-074901-0.50012-5

Amin MT, Fatema K, Rahman MA, Haque T, Choudhuri MS. Investigation of hemotoxicologic potential of an ayurvedic preparation Kutajarista used in Sprue syndrome after chronic administration to male Sprague-Dawley rats. African J Pharm Pharmacol 2020;14(8):308-15. DOI: https://doi.org/10.5897/AJPP2020.5174

Wolford ST, Schoer RA, Gohs FX, Gallo PP. Reference range database for serum chemistry and haematology values in laboratory animals. J Tox Environ Hlth, 1986;18:161-88. DOI: https://doi.org/10.1080/15287398609530859

Tatsumi N, Tsuda I, Furota A, Takubo T, Hayashi M, Matsumoto H. Principle of Blood Cell Counter- Development of Electric Impedance Method. Sysmex J Int. 1999;9:8-20.

van Kampen EJ, Zijlstra WG. Standardization of hemoglobinometry II. The hemiglobincyanide method. Clinica Chimica Acta. 1961;6(4):538-44. DOI: https://doi.org/10.1016/0009-8981(61)90145-0

Fred HL. Maxwell Myer Wintrobe: new history and a new appreciation. Texas Heart Institute Journal. 2007;34(3):328.

Colditz GA, editor. The SAGE encyclopedia of cancer and society. SAGE Publications. 2015. DOI: https://doi.org/10.4135/9781483345758

Nipa JA, Amin MT, Rahman MA, Sharmin F, Karmakar P, Choudhuri MS. Investigation of hematologic parameter of an Ayurvedic preparation “Amalaki Rasayan” used in jaundice after chronic administration to sprague-dawley rats. J. Biomed. Ther. Sci. 2016;3(1):1-6.

Saha N, Sikder MM, Uddin MA, Akter FA, Asha UH, Sony TA. Hematological Studies of an Ayurvedic Medicine “Vata Gajendra Singha” Used in Rheumatoid Arthritis After Chronic Administration to Male Sprague-Dawley Rats. Trop J Nat Prod Res. 2023;7(3):2492-7.

Westergren A. Diagnostic tests: the erythrocyte sedimentation rate range and limitations of the technique. Triangle. 1957;3(1):20-5.

Dejana E, Callioni A, Quintana A, Gaetano G. Bleeding time in laboratory animals. II A comparison of different assay conditions in rats. Thromb Res. 1979;15(1-2):191-7. DOI: https://doi.org/10.1016/0049-3848(79)90064-1

Sikder MM, Chakraborty P, Mahbub MR, Zulfiquar TN, Neon MN, Saha N, et al. Preclinical hematological profile studies of an ayurvedic medicine “Siddha Makardhwaja” after chronic administration to male Sprague-dawley rats. Int J Basic Clin Pharmacol 2018;7:93–7. DOI: https://doi.org/10.18203/2319-2003.ijbcp20175681

Saha N, Sikder MM, Uddin MA, Akter F, Asha UH, Sony T, et al. Hematological Studies of an Ayurvedic Medicine “Vata Gajendra Singha” used in rheumatoid arthritis after chronic administration to Male Sprague-Dawley Rats. Trop J Nat Prod Res. 2023;7:2492–7. DOI: https://doi.org/10.26538/tjnpr/v7i3.4

Bloom JC, Lewis HB, Sellers TS, Deldar A. The hematologic effects of cefonicid and cefazedone in the dog: a potential model of cephalosporin hematotoxicity in man. Toxicology and applied Pharmacol. 1987;90(1):135-42. DOI: https://doi.org/10.1016/0041-008X(87)90314-0

Bleeker JS, Hogan WJ. Thrombocytosis: diagnostic evaluation, thrombotic risk stratification, and risk‐based management strategies. Thrombosis. 2011;2(1):536062. DOI: https://doi.org/10.1155/2011/536062

Md. Mamun Sikder. Ayurvedic Medicine: A Traditional Medical System and Its Heavy Metal Poisoning. Chonnam Med J. 2024;60(2):23-8. DOI: https://doi.org/10.4068/cmj.2024.60.2.97